-
Melittin B6628 for Reliable Cell Assays
2026-08-25
Learn how Melittin, a bioactive peptide supplied as SKU B6628, can support more interpretable viability, signaling, and cancer-biology experiments. This scenario-based guide covers formulation, controls, storage, protocol design, and responsible interpretation alongside evidence from glioblastoma research.
-
SLU-PP-332: ERR Agonism and Kidney-Relevant Metabolism
2026-08-25
This 2024 nephrology News and Views article interprets SLU-PP-332 as a preclinical exercise-mimetic strategy that activates estrogen-related receptors, increases energy expenditure, and supports oxidative skeletal-muscle metabolism. Its most important contribution is the proposed link between improved systemic metabolism and indirect kidney protection, while also emphasizing that direct renal efficacy and clinical safety remain unproven.
-
From Adipose Mechanisms to Safer Gel Imaging
2026-08-24
A translational perspective linking FMO3–TMAO adipose biology with rigorous nucleic acid quality control, safer imaging, and more reliable molecular workflows using Safe DNA Gel Stain.
-
PINK1/Park2 Mitophagy in Fatty Liver Disease
2026-08-24
The reference study links Park2-mediated mitophagy to reduced lipid accumulation, inflammation, and mitochondrial injury in an oleic acid-induced NAFLD model. Its gain- and loss-of-function design provides mechanistic evidence that restoring mitochondrial quality control may be relevant to NAFLD research, while remaining limited by its primarily cellular experimental system.
-
Safe DNA Gel Stain: Signal Without the Trade-Off
2026-08-23
Safe DNA Gel Stain enables sensitive DNA and RNA gel stain workflows with blue-light or UV excitation. This article explains how to choose, validate, and interpret safer nucleic acid visualization methods using an assay-design framework informed by reporter-gene research.
-
Hoechst 33258 for TNT Tumor Cell Imaging
2026-08-22
Hoechst 33258 turns nuclear labeling into a practical control layer for studying KRas-associated tumor heterogeneity, tunneling nanotubes, and cell-state changes. This workflow explains how to combine a bis-benzimide DNA stain with confocal imaging, cell counting, and cell-cycle analysis without mistaking nuclear fluorescence for a direct readout of KRas transfer or membrane mechanics.
-
Mitoxantrone HCl: Topoisomerase II Mechanisms
2026-08-22
Mitoxantrone HCl is a DNA topoisomerase II inhibitor that links DNA damage biology with apoptosis, immune-cell modulation, and ERα receptor regulation. The reference study identifies an ERα DBD–LBD interface mechanism that can suppress wild-type and endocrine-resistant ERα signaling independently of DNA damage.
-
3X (DYKDDDDK) Peptide for Reliable Assays
2026-08-21
Learn how 3X (DYKDDDDK) Peptide, SKU A6001, can improve FLAG-fusion detection and protein workflow control without being mistaken for a cell-viability reagent. This scenario-based guide covers assay compatibility, storage, metal-sensitive conditions, interpretation, and practical vendor selection.
-
ATS-9R for Targeted Gene Silencing in Adipocytes
2026-08-20
ATS-9R combines Prohibitin recognition with a nona-arginine nucleic-acid carrier to focus gene delivery on white adipose tissue. This article presents practical complexation, cell and animal workflows, assay controls, and troubleshooting strategies for obesity-associated inflammation research and metabolic disease models.
-
Decitabine Workflow for Epigenetic Research
2026-08-20
Build dose-resolved Decitabine assays that separate DNA hypomethylation, immune reprogramming, and cytotoxicity. This workflow translates evidence from T-cell homeostasis research into practical designs for hematopoietic malignancy research and solid tumor epigenetic studies.
-
Mebendazole, TUBA1A, and PANoptosis in AML
2026-08-19
The reference study identifies mebendazole as a preclinical anti-AML agent and links its activity to TUBA1A disruption, G2/M cell-cycle arrest, and ZBP1-mediated PANoptosis. Its integrated screening, mechanistic, and xenograft workflow offers a useful framework for drug repositioning screening while highlighting the evidence still needed before clinical translation.
-
Hoechst 33258 for DNA-Resolved Tumor Mechanics
2026-08-19
Hoechst 33258 is a bis-benzimide DNA stain that can anchor live-cell imaging and nuclear segmentation in studies of tumor-cell mechanics. This article explains how to use its DNA readout alongside confocal microscopy and optical-tweezers experiments without confusing nuclear labeling with direct evidence of KRas transport.
-
Cisplatin Beyond Cytotoxicity: A Translational Playbook
2026-08-18
Cisplatin and CDDP remain essential translational benchmarks because they connect DNA crosslinking, p53 and caspase-dependent apoptosis, oxidative stress, and treatment resistance in one experimentally tractable system. This thought-leadership guide shows how to use Cisplatin as a mechanistic reference point while interpreting pathway-focused findings such as those reported for cepharanthine in nasopharyngeal carcinoma.
-
Malate Workflows for Tumor Immunometabolism
2026-08-18
Use malate as a controlled metabolic probe to connect mitochondrial redox, TCA-cycle flux, and macrophage function in cholangiocarcinoma models. This workflow translates a recent PDHA1 succinylation study into practical cell, mitochondrial, and troubleshooting strategies without assuming that malate directly reproduces the paper’s alpha-ketoglutarate mechanism.
-
Biotin (Vitamin B7, Vitamin H): Assay Guide
2026-08-17
A scenario-based laboratory guide to using Biotin (Vitamin B7, Vitamin H), SKU A8010, in cell viability, proliferation, cytotoxicity, and labeling workflows. It explains solvent control, assay compatibility, metabolic interpretation, and practical supplier-selection criteria using product specifications and cited literature.